CIK 0001649094
- Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464233385
- Phone
- +1 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale SVP, GEN COUNSEL & CORP SEC sold 1,667 shares at an average $76.37 ($127,304)
- 4 Planned sale CHIEF OPERATING OFFICER sold 3,000 shares at an average $76.34 ($229,013)
- 4 Planned sale CHIEF EXECUTIVE OFFICER sold 2,616 shares at an average $76.33 ($199,690)
- 4 Planned sale CHIEF EXECUTIVE OFFICER sold 15,000 shares at an average $75.64 ($1,134,579)
- 4 Planned sale PRESIDENT AND CFO sold 8,000 shares at an average $71.92 ($575,375)
- 4 Shares withheld for taxes SVP, GEN COUNSEL & CORP SEC gave up 335 shares (to pay taxes)
- 4 Grant or award Director acquired 1,550 shares (grant or award)
- 4 Grant or award Director acquired 1,550 shares (grant or award)
- 4 Grant or award Director acquired 1,550 shares (grant or award)
- 4 Grant or award Director acquired 1,550 shares (grant or award)
- 4 Grant or award Director acquired 1,550 shares (grant or award)
- 4 Grant or award Director acquired 1,550 shares (grant or award)
- 4 Grant or award Director acquired 1,550 shares (grant or award)
- 4 Planned sale Director sold 18,200 shares at $73.00 ($1,328,600)
- 4 Planned sale SVP, GEN COUNSEL & CORP SEC sold 1,667 shares at an average $72.06 ($120,127)
- 4 Planned sale CHIEF OPERATING OFFICER sold 3,000 shares at an average $71.99 ($215,961)
- 4 Planned sale CHIEF EXECUTIVE OFFICER sold 2,616 shares at an average $72.06 ($188,512)
- 4 Planned sale CHIEF EXECUTIVE OFFICER sold 15,000 shares at an average $69.43 ($1,041,408)
Page 8 of 22 · 421 filings